Cholangiocarcinoma-UK, an affiliate of the British Association for Study of Liver Disease (BASL), is a multi-disciplinary Special Interest Group (SIG) of clinicians, scientists and patient advocates whose purpose is to facilitate collaborative research, enhance service development and raise awareness of Cholangiocarcinoma.
Aims of Cholangiocarcinoma UK
• Be the recognised leading authority on Cholangiocarcinoma in the UK
• Become affiliated to other relevant major national organisations e.g. BASO, BSG
• Facilitate basic science and clinical research as well as sample collection, including for biomarker development
• Improve the pathway to collaborative clinical trials and opportunities for research funding
• Update national guidelines and advise on policy and best practice
• Optimise and standardise clinical management across the country
• Monitor epidemiological trends accurately.
|Chair||Professor Shahid Khan||Imperial College, London|
|Secretary||Professor Derek Manas||Freeman Hospital, Newcastle upon Tyne|
|Patient advocate||Helen Morement||AMMF – The Cholangiocarcinoma Charity|
|Basic science representatives||Professor David Bates||University of Nottingham|
|Dr Luke Boulter||MRC Human Genetics Unit, Edinburgh|
|Dr Chiara Braconi||University of Glasgow|
|Dr Sheela Jayaraman||University of Birmingham|
|Endoscopy representative||Professor Steve Pereira||University College / Royal Free Hospital, London|
|Hepatology representative||Dr Simon Rushbrook||Norfolk & Norwich University Hospitals|
|Clinical oncology representative||Professor Maria Hawkins||University College, London|
|Medical oncology representatives||Professor John Bridgewater||University College, London|
|Professor Juan Valle||Christie NHS Foundation Trust / University of Manchester|
|Pathology representative||Dr Tim Kendall||University of Edinburgh / Royal Infirmary Edinburgh|
|Surgery representatives||Professor Brian Davidson||Royal Free Hospital, London|
|Professor Nigel Heaton||King's College Hospital, London|
|Mr Hassan Malik||Aintree University Hospital|
|Trainee representatives||Dr Pilar Acedo||University College, London|
|Dr Leonard Marc Quinn||University of Liverpool|
Annual report 2018-19 - Download Annual report_2018-19_CCA-UK.pdf.
1st meeting - 7 December 2018
Welcome presentation, Shahid Khan, St Mary’s Hospital, London - Download Welcome.pdf
Presentation on the patient/healthcare professional partnership, Helen Morement, AMMF - Download The patient_healthcare professional partnership.pdf
Presentation on Epidemiology and aetiology: What we don’t know & how can we find out, Shahid Khan, St Mary’s Hospital, London - Download Epidemiology and aetiology_What we dont know and how we can find out.pdf
Presentation on Ensuring quality: Centres of “excellence/expertise”?, Hassan Malik, Aintree University Hospital Download Ensuring quality_Centres of excellence and expertise.pdf
Presentation on Medical oncology: The unmet needs and how we meet them, John Bridgewater, UCL & Juan Valle, Christie NHS Foundation Trust - Download Medical oncology_The unmet needs and how we meet them.pdf
Presentation on Clinical oncology: Establishing novel roles in CCA therapy, Maria Hawkins, University of Oxford - Download Clinical oncology_Establishing novel roles in CCA therapy.pdf
2nd meeting - 14 November 2019
Presentation on Cholangiocarcinoma and liver fluke infection in Lao PDR, Peter Odermatt, Swiss Tropical and Public Health Institute - Download CCA and Liver Fluke Infection in Lao_P Odermatt.pdf
Presentation on Universal tumour antigens in primary liver cancers: Cholangiocarcinoma and Hepatocellular carcinoma are differentUniversal tumour antigens in primary liver cancers: Cholangiocarcinoma and Hepatocellular carcinoma are different, Ollie Rupar, University of Plymouth - Download Universal tumour antigens in primary liver cancers_Ollie Rupar.pdf
Presentation on Single molecule detection of osteopontin in nanopores using DNA molecular carriers, Micol Damiani, Imperial College London - Download Single molecule detection of osteopontin in nanopores_M Damiani.pdf
Presentation on the investigation of virus-driven intrahepatic Cholangiocarcinoma through dysregulated hepatic differentiation, Alex Kilvington, University of Leeds - Download Virus-Driven Intrahepatic CCA_A Kilvington.pdf
Presentation on the role of mesenchymalcells in Cholangiocarcinoma, Mireia Sueca Comes, University of Nottingham - Download Role of Mesenchymal Cells in CCA_M Sueca-Comes.pdf
Presentation on non-coding RNAs and the biology underpinning potential new precision medicines in Cholangiocarcinoma, Chiara Braconi, University of Glasgow - Download RNAs and biology underpinning potential new precision medicines_C Braconi 1.pdf
Presentation on Delphi process on next key questions in basic science of Cholangiocarcinoma, Shahid Khan, Imperial College London - Download Clinical and Research Priorities in CCA_S Khan.pdf
The AMMF is represented on the CCA-UK Steering Committee and is the UK’s only cholangiocarcinoma charity - http://ammf.org.uk/.
Global CCA Alliance
The Global Cholangiocarcinoma Alliance (GCA) has united to establish a global voice in CCA through community collaborations. The GCA has a shared vision to raise the awareness of CCA, in order to improve prevention, survival and the quality of life of CCA patients globally. CCA-UK is a partner in this Alliance. For more information, visit https://globalccaalliance.com/en.
News & Meetings
Register Now for the next meeting of the CCA-UK SIG which is taking place as a webinar via Zoom on:
Date: Monday 14th December
Time: 17:30 - 19:30
Free to attend and all welcome.
Visit the Events listing page of the website for more details.